Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactobiogen
- Development stage
- Unknown
- Lead developer
- Laves-Arzneimittel
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Lactobiogen is a probiotic dietary supplement developed by Laves-Arzneimittel GmbH to support intestinal health and the immune system. It contains a concentrated blend of four specific lactic acid-producing bacterial strains: *Bifidobacterium lactis* BB-12, *Lactobacillus acidophilus* LA-5, *Lactobacillus delbrueckii subsp. bulgaricus* LBY-27, and *Streptococcus thermophilus* STY-31. These strains are delivered in a capsule form designed to survive stomach acid and colonize the intestinal tract. The product is primarily used to restore natural intestinal flora, particularly following antibiotic treatment, and to maintain overall digestive and immune function. It is free from common allergens such as lactose, gluten, and soy, and contains no animal-derived ingredients.
- Brand names
- Lactobiogen
Beyond the preview
Go deeper on Lactobiogen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lactobiogen.